Boston Scientific Corp Stock Today
| BSX Stock | USD 100.72 3.67 3.52% |
PerformanceSolid
| Odds Of DistressVery Low
|
Boston Scientific is trading at 100.72 as of the 25th of February 2025; that is 3.52% down since the beginning of the trading day. The stock's open price was 104.39. Boston Scientific has a very small chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Note, on November 1, 2023, Senator Markwayne Mullin of US Senate acquired under $15k worth of Boston Scientific Corp's common stock.
Business Domain Health Care Equipment & Services | IPO Date 18th of May 1992 | Category Healthcare | Classification Health Care |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.48 B outstanding shares of which 10.45 M shares are currently shorted by investors with about 1.8 days to cover. More on Boston Scientific Corp
Moving against Boston Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Boston Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Michael Mahoney | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, ARCA Institutional, Healthcare, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBoston Scientific can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Boston Scientific's financial leverage. It provides some insight into what part of Boston Scientific's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Boston Scientific Corp (BSX) is traded on New York Stock Exchange in USA. It is located in 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 and employs 53,000 people. Boston Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 154.06 B. Boston Scientific Corp runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.48 B outstanding shares of which 10.45 M shares are currently shorted by investors with about 1.8 days to cover.
Boston Scientific Corp has about 928 M in cash with 3.44 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Check Boston Scientific Probability Of Bankruptcy
Ownership AllocationBoston Scientific holds a total of 1.48 Billion outstanding shares. The majority of Boston Scientific Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Boston Scientific Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Boston Scientific. Please pay attention to any change in the institutional holdings of Boston Scientific Corp as this could imply that something significant has changed or is about to change at the company. Please note that on November 1, 2023, Senator Markwayne Mullin of US Senate acquired under $15k worth of Boston Scientific Corp's common stock.
Check Boston Ownership Details
Boston Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bollard Group Llc | 2024-12-31 | 20.7 M | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 20.5 M | |
| Norges Bank | 2024-12-31 | 19.7 M | |
| Massachusetts Financial Services Company | 2024-12-31 | 19.7 M | |
| Franklin Resources Inc | 2024-12-31 | 16.5 M | |
| Amvescap Plc. | 2024-12-31 | 15.8 M | |
| Hhg Plc | 2024-12-31 | 15 M | |
| Northern Trust Corp | 2024-12-31 | 14.6 M | |
| Goldman Sachs Group Inc | 2024-12-31 | 12.9 M | |
| Blackrock Inc | 2024-12-31 | 139 M | |
| Vanguard Group Inc | 2024-12-31 | 132.9 M |
Boston Scientific Historical Income Statement
Boston Stock Against Markets
Boston Scientific Corporate Directors
| Edward Ludwig | Lead Independent Director | Profile | |
| Donna James | Independent Director | Profile | |
| Stephen MacMillan | Independent Director | Profile | |
| Ellen Zane | Independent Director | Profile |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.